中文摘要：

目的在比较国产和进口支架性能的基础上,评价益气活血中成药联合西药抗黏附效果,为经皮冠状动脉介入治疗术（PCI）术后益气活血中成药的临床使用提供依据。方法采用Meta分析对数据库中从建库时间至2016年5月发表的PCI术后患者的随机对照试验进行系统评价。纳入9篇文献,共1173例患者,各个研究基线资料具有可比性,均报道为随机方法。评价指标包括国产和进口支架血管再狭窄例数和益气活血中成药联合西药治疗PCI术后细胞间黏附分子-1（ICAM-1）水平。结果国产支架与进口支架血管再狭窄发生例数[OR=1.11,95%CI（0.51,2.40）,Z=0.26,P=0.80];常规西药与益气活血中成药联合西药治疗PCI术后患者的ICAM-1水平[MD=-51.37,95%CI（-79.91,-22.83）,Z=3.53,P=0.004]。结论对使用国产和进口支架的患者进行PCI术后随访12~24月,患者的血管再狭窄发生例数无统计学差异,国产与进口支架效果相似;益气活血中成药联合西药对PCI术后抗黏附效果明显优于常规西药单独使用。

英文摘要：

Objective To assess the anti-adhesion effects of combination of application of Chinese traditional medicine for supplementing Qi and activating blood western medicine based on the systematical comparison of the restenosis rate between the domestic and imported stent so as to provide the basis for the clinical application of Chinese traditional medicine for supplementing Qi and activating blood in treatment of post-PCI（Percutaneous Coronary Intervention） coronary heart diseases. Methods All the randomized controlled trials（RCT） on treatment of post-PCI coronary heart diseases that were published in the database from the establishment of the database to May 2016 were retrieved and analyzed by using Meta analysis. Altogether 9 pieces of paper and 1173 patients were enrolled in the study. The baseline data of each study were comparable and all the studies were reported to use the stochastic methods. Evaluation indicators included the restenosis number of the domestic and imported stent as well as the effects of combination of application of Chinese traditional medicine for supplementing Qi and activating blood western medicine on the ICAM-1（Intercellular Cell Adhesion Molecule-1） levels of post-PCI patients. Results The vascular restenosis rate of the domestic and imported stent was [OR=1.11, 95%CI（0.51, 2.40）, Z=0.26, P=0.80]; while, the ICAM-1 levels for post-PCI patients treated with the combination of application of Chinese traditional medicine for supplementing Qi and activating blood western medicine were [MD=-51.37, 95%CI（-79.91,-22.83）, Z=3.53, P=0.004]. Conclusion According to the 12- to 24-month follow-up of post-PCI coronary heart disease patients treated with the domestic and imported stent, the myocardial infarction recurrence of patients treated with the domestic stent was similar to those treated with the imported stent, without statistically significant differences. The combination of application of Chinese traditional medicine for supplementing Qi and activating blood western medi